Skip to main content

Bausch Health Companies Inc(BHC-T)
TSX

Today's Change
Real-Time Last Update

Stocks in play: Bausch Health Companies Inc.

Baystreet - Thu Dec 21, 2023

Today announced positive topline results from the Company's Phase 2 study evaluating Amiselimod, an investigative S1P antagonist, for the treatment of ulcerative colitis. Bausch Health Companies Inc. shares T.BHC are trading up $0.07 at $9.76.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe